EcoDrugPlus

Metabotropic Glutamate Receptor 3-Like

Ensembl ID : ENSLBEG00000025951
Gene Symbol: LOC110002772
3 Cross references
215 Possible Orthologues:

Metabotropic Glutamate Receptor 5-Like

Ensembl ID : ENSLBEG00000014174
Gene Symbol: LOC109988368
3 Cross references
211 Possible Orthologues:

Metabotropic Glutamate Receptor 5-Like

Ensembl ID : ENSLBEG00000004743
Gene Symbol: LOC109995793
3 Cross references
213 Possible Orthologues:

Methionyl Aminopeptidase 2

Ensembl ID : ENSLBEG00000008691
Gene Symbol: METAP2
4 Cross references
220 Possible Orthologues:

Microtubule-Associated Protein Tau-Like

Ensembl ID : ENSLBEG00000018556
Gene Symbol: LOC110001835
2 Cross references
205 Possible Orthologues:

Mitogen-Activated Protein Kinase 1

Ensembl ID : ENSLBEG00000018048
Gene Symbol: MAPK1
3 Cross references
209 Possible Orthologues:

Mitogen-Activated Protein Kinase 1-Like

Ensembl ID : ENSLBEG00000024780
Gene Symbol: LOC109998393
3 Cross references
197 Possible Orthologues:

Mitogen-Activated Protein Kinase 10

Ensembl ID : ENSLBEG00000017081
Gene Symbol: LOC109990779
3 Cross references
88 Possible Orthologues:

Mitogen-Activated Protein Kinase 11

Ensembl ID : ENSLBEG00000027802
Gene Symbol: MAPK11
3 Cross references
198 Possible Orthologues:

Mitogen-Activated Protein Kinase 14

Ensembl ID : ENSLBEG00000010849
Gene Symbol: MAPK14
3 Cross references
224 Possible Orthologues:

Mitogen-Activated Protein Kinase 14a

Ensembl ID : ENSLBEG00000015284
Gene Symbol: LOC109994795
3 Cross references
206 Possible Orthologues:

Mitogen-Activated Protein Kinase 8

Ensembl ID : ENSLBEG00000000152
Gene Symbol: LOC109992271
3 Cross references
224 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).